Q1 2023 Stratasys Ltd Earnings Call
Participants
Eitan Zamir; CFO; Stratasys Ltd.
Yoav Zeif; CEO; Stratasys Ltd.
Yonah Lloyd; CCO & VP of IR; Stratasys Ltd.
Ananda Prosad Baruah; MD; Loop Capital Markets LLC, Research Division
Blake Stuart Keating; Research Analyst; William Blair & Company L.L.C., Research Division
Danny James Eggerichs; Research Analyst; Craig-Hallum Capital Group LLC, Research Division
James Andrew Ricchiuti; Senior Analyst; Needham & Company, LLC, Research Division
Shannon Siemsen Cross; Research Analyst; Crédit Suisse AG, Research Division
Troy Donavon Jensen; Senior Research Analyst; Lake Street Capital Markets, LLC, Research Division
Presentation
Operator
Greetings, and welcome to the Stratasys Limited First Quarter 2023 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Yonah Lloyd, Chief Communications Officer and Vice President of Investor Relations. Thank you. Please go ahead.
Yonah Lloyd
Good morning, everyone, and thank you for joining us to discuss our 2023 1st quarter financial results. On the call with us today are our CEO, Dr. Yoav Zeif; and our CFO, Eitan Zamir. I would like to remind you that access to today's call, including the slide presentation, is available online at the web address provided in our press release. In addition, a replay of today's call, including access to the slide presentation, will also be available and can be accessed through the Investor Relations section of our website.
Please note that some of the information you will hear during our discussion today will consist of forward-looking statements including, without limitation, those regarding our expectations as to our future revenue, gross margin, operating expenses, taxes and other future financial performance and our expectations for our business outlook. All statements that speak to future performance, events, expectations or results are forward-looking statements. Actual results or trends could differ materially from our forecast. For risks that could cause actual results to be materially different from those set forth in forward-looking statements, please refer to the risk factors discussed or referenced in Stratasys' annual report on Form 20-F for the 2022 year.
Please also refer to our operating and financial review and prospects for 2022 and for the first quarter of 2023, which are included as Item 5 of our annual report on Form 20-F for 2022 and Exhibit 99.2 to the report on Form 6-K that we are furnishing to the SEC today, respectively. Please also see the press release that announces our earnings for the first quarter of 2023 which is attached at Exhibit 99.1 to a separate report on Form 6-K that we are furnishing to the SEC today. Our reports on Form 6-K that we furnished to the SEC on a quarterly basis and throughout the year, provide updated current information regarding our operating results and material developments concerning our company.
Stratasys assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates. As in previous quarters, today's call will include GAAP and non-GAAP financial measures. The non-GAAP financial measures should be read in combination with our GAAP metrics to evaluate our performance. Non-GAAP to GAAP reconciliations are provided in tables in our slide presentation and today's press release. I will now turn the call over to our Chief Executive Officer, Dr. Yoav Zai. Yoav?
Yoav Zeif
Thank you, Yonah. Good morning, everyone. And thank you for joining us. Before I discuss the business highlights, I would like to comment briefly on the 3 unsolicited proposals we received in recent months from Nano Dimension to acquire Stratasys initially for $18 then $19.55 and subsequently for $20.05 per share in cash. As previously announced, consistent with its fiduciary duties and in consultation with its independent financial and legal advisers, the Stratasys Board carefully reviewed and evaluated each proposal.
Following its review, the Stratasys Board unanimously rejected all 3 proposals because they each substantially undervalued Stratasys in light of the company's standalone prospects. As we have articulated previously, Nano is in the midst of multiple lawsuits with its shareholders, involving the control and governance of the company. And as a result, serious questions remain about the legal legitimacy of the Nano offer. The Stratasys Board and management team are committed to enhancing shareholder value and continue to successfully execute on the company's growth strategy. We are making strong progress towards becoming a highly profitable $1 billion revenue company as part of its fiduciary duties, the Board will review any Bonafide proposal for the company and weigh it against our stand-alone plan.
We are not going to comment further on this matter today. We appreciate you keeping your questions focused on our results as the focus of this call is our performance for the quarter. Our excellent results for Q1 2023 represent another consecutive quarter of solid performance despite an increasingly challenging macro backdrop. We continue to execute on our winning strategy, driven by our broad global and diverse set of systems, materials and software solutions. With our leadership position, our 5 key technologies, resilient business model and strong financial profile, we believe we are positioned to accelerate growth and drive shareholder returns not only for today, but also for years to come.
Our confidence is reflected in the medium-term forecast we are announcing today. Eitan will provide further details during his remarks, but we expect to surpass $1 billion in revenue in 2026 with substantial profitability. In terms of our first quarter results, we are seeing stronger utilization by our customers than ever before, which drove all-time record revenues in both consumables and customer service. As we have noted in the past few earnings calls, macro-related pressure on CapEx budgets are causing longer sales cycle and occasional deferrals of orders. Our OEM revenue was relatively flat to the first quarter of last year, adjusted for FX and divestments primarily due to the impact of those factors on hardware purchases.
The manufacturing trend of onshoring, deglobalization and just-in-time production are driving opportunities for growth. Stratasys is positioned to take advantage of these opportunities given our combination of proven market-leading system in FDM and PolyJet, new technology offerings in P3, SAF and stereolithography the broadest set of polymer materials in the industry, unified software platform across the portfolio and unmatched go-to-market capabilities. Along with our robust balance sheet, this sets us apart and will enable us to sustain our organic growth and expand our reach via the pursuit of external opportunities, engagement with both our installed base and new customers remain strong.
We continue to expand our customer reach across our entire suite of technologies, particularly targeting manufacturing applications. We have demonstrated a resilient and recurring business model that delivered gross margin this quarter that were flat compared to the year-ago period and also kept OpEx spending as a percentage of revenue nearly flat to the corresponding period last year, even with a reduction in revenues. As a result of our efforts and despite the headwinds faced, I'm proud that we delivered positive adjusted earnings per share for the seventh consecutive quarter.
Our vision for the future of additive manufacturing and in turn, our ability to deliver greater returns for our shareholders is more robust than ever. We ended the quarter with a strong balance sheet that includes no debt and $288 million in cash and equivalents. This continues to support our growth through organic investments and accretive acquisition opportunities, including early-stage but highly compelling technology-driven businesses, which we believe will improve results as we leverage our infrastructure and experience to strengthen operations.
Now let me turn to the exciting achievements and milestones reached since the end of 2022. In February, we introduced the first monolithic multicolor 3D-printed dental solution through our prudent resin. Our first ever FDA-cleared medical device -- as a reminder, dental overall is a 50 billion tonne and is fast-growing industry for additive manufacturing. The prudent solution enables labs to create permanent natural-looking dentures with accurate tooth structure, gum, shade and translucency in one continuous print.
The resin is designed for exclusive use in our J5 DentaJet printers using GrabCAD Print software and provides DentaLab the ability to scale manufacturing with simplified workflow and reduce processing time. To deliver the best quality dentures available in the market today, we already have several new customers and many of the large dental labs are actively evaluating the solution. In February, we launched a new J3 DentaJet printer, opening up more opportunities to Stratasys. Such as implant models and surgical guide for Dental Labs. It recently received an excellent reception at the dental industry's largest trade show. Our superior accuracy provides an entry point for customers ready to step up from lower-quality solutions, one of the world's largest Dental Lab said it tripled its daily production volume with the J3 relative to their previous system.
Moving to our medical highlight. In February, we signed an agreement with Ricoh USA to provide on-demand 3D-printed anatomic models for clinical settings. Our patient-specific 3D-printed solutions combined our 3D printing technology, the cloud-based segmentation as a service solution from Axial3D and precision additive manufacturing service from Ricoh into one convenient solution. This represents an expansion of the relationship between Ricoh 3D for health care and Stratasys. After quarter end, we forged a joint development and commercialization agreement with CollPlant Biotechnologies to transform health care with industrial-scale bioprinting of tissues and organs.
The initial focus of the relationship will be around development of bioprinting solutions for CollPlant regenerative breast implants, a $2.6 billion opportunity. Further, the combination of our P3 technology-based bioprinter with their RH collagen-based bioinks is also ideal for future innovation and production of additional human tissues and organs. Both companies agreed to cross-promote our respective bioprinting product. On the industrial side, in March, we secured a multisystem opportunity with Götz Maschinenbau for our mass production H350 3D printers. The sales involved 4 additional systems to add to the German service bureau meet growing demand for high-quality and used parts. Götz is already a valued partner that also deploys FDM and PolyJet-based Stratasys printers.
In addition, in early April, we closed the acquisition of Covestro's additive manufacturing materials business which expands our differentiated 3D printed material offering in stereolithography, DLP and powders to address more manufacturing industry applications. Covestro is expected to be immediately accretive and includes R&D facilities, global development and sales teams and a portfolio of 60 materials for additive manufacturing. Together, we will be able to address more applications faster, pushing the boundaries of what is possible in additive manufacturing.
We are also growing our focus on adding value for customers while increasing recurring revenue through significant software enhancements. Last month, we introduced g GrabCAD Print Pro, which provides a major productivity boost for our customer. The initial rollout is for our SaaS and FDM systems, applicable for end-use parts and production scale volumes, tooling and prototypes. We plan to make this software update available across our other 3 technologies as well. The annual subscription package includes quality management capabilities from our recent acquisition as well as added functionality from third-party partners, 3 value-add plug-in partners available in the initial release as we continue growing our ecosystem, our Castor, AlphaSTAR and Cognitive Design system.
These advances in software are helping Stratasys integrate into scaled-up Industry 4.0 infrastructure. In fact, the advanced manufacturing research center at the University of Sheffield has been able to successfully incorporate Stratasys data into its Factory Plus architecture right alongside CNC machines, robot arms and other mainstream factory equipment. In addition, Stratasys expansion into software is helping drive opportunities with systems and materials. Our previously announced OpenAM software is now widely available to customers, and we are seeing it help unlock Fortus 450 printer opportunities with manufacturing customers that are interested in FDM for end-use part applications due to the greater flexibility it provides in material selection.
That is also a key driver of customers' interest in Origin One printers as well. Our technological innovation, best-in-class sales channel and key partnership are contributing to our effort to build on our meaningful foundation for growth that will drive our industry leadership for the long term. I will now turn the call over to our CFO, Eitan Zamir, to share the financial results, update our outlook for the rest of 2023 and outline our medium-term forecast. Eitan?
Eitan Zamir
Thank you, Yoav. And good morning, everyone. As Yoav mentioned, we achieved solid results against the increasingly challenging macro backdrop in the quarter. We are particularly proud of how we held the line on both growth and operating margin, maintaining profitability in a challenging environment due to the right infrastructure and tight OpEx management as we continue to drive efficiencies across the platform.
Our results demonstrate the resilience that our diversified offering provides. Despite the expected slowdown in new printer sales, we saw continued utilization of our systems by our customers driving record recurring revenues from consumables and customer service, helping us deliver our seventh straight quarter of adjusted profitability. Now let me dive deeper into the numbers. For the first quarter, consolidated revenue of $149.4 million was down 2.6% compared to Q1 2022. Adjusted for divestitures and at constant currency and down 8.6% compared to the unadjusted revenue.
Revenue in our OEM business, which excludes MakerBot as well as FDM, was down 0.9% at constant currency from the prior year period. Product revenue in the first quarter declined by 10.7% to $101 million compared to the same period last year or by 5.1%, excluding divestitures and on a constant currency basis. Within product revenue, system revenue declined 25.8% to $40.5 million compared to $54.5 million in the same period last year. Excluding divestitures and on a constant currency basis, revenue was down 19.2%. Consumables revenue rose by 3.3% to $60.5 million compared to the same period last year, rose by 5.2% on a constant currency basis and grew by 7.5% in our OEM business at constant currency.
This represents a record level for Stratasys and signals that utilization rate of our systems we have sold are strong. Services revenue, including FDM, was $48.4 million, down 3.9% as compared to the same period last year. After backing out FDM, it was up 2.4% and up 3.9% at constant currency. And our customer service revenue was the highest ever, a further testament to the growing utilization rates of our system. Within service revenue, customer support revenue grew 4.9% compared to the same period last year, and increased by 6.4% on a constant currency basis.
Now turning to gross margins. GAAP gross margin was 43.8% for the quarter compared to 42.6% for the same period last year. Non-GAAP gross margin was 47.3% for the quarter, flat compared to the same period last year. Our ability to hold gross margin unchanged despite the decrease in revenue is a testament to our relentless focus on cost savings across the platform. Gross margins also benefited from the divestment of MakerBot last year, partially offset by the FX impact. GAAP operating expenses were $82.2 million compared to $89.3 million during the same period last year.
Non-GAAP operating expenses were $69.2 million compared to $75.3 million during the same period last year. Non-GAAP operating expenses were 46.3% of revenue for the quarter compared to 46.1% for the same period last year. As we continue to focus on operational efficiency improvement. We continue to efficiently manage our costs, delivering relatively low OpEx despite the lower revenue. Reflecting the scalability of our model. Regarding our consolidated earnings. GAAP operating loss for the quarter was $16.8 million, compared to a loss of $19.6 million for the same period last year.
Non-GAAP operating income for the quarter was $1.5 million compared to $2 million for the same period last year. The change reflects the decline in overall revenue, offset somewhat by 8.2% improvement in non-GAAP OpEx. GAAP net loss for the quarter was $22.2 million or $0.33 per diluted share compared to a net loss of $20.9 million or $0.32 per diluted share for the same period last year. Non-GAAP net income for the quarter was $1.1 million or $0.02 per diluted share compared to net income of $1.2 million or $0.02 per diluted share in the same period last year.
Again, this was our seventh consecutive quarter of delivering positive net income on an adjusted basis. Adjusted EBITDA was $7 million for the quarter compared to $8.1 million in the same period last year, which reflects a flat result year-over-year on a percentage of revenue basis. We used $17.9 million of cash in our operations during the first quarter. Compared to the use of $16.1 million of cash from operations in the same quarter last year. The use of cash was primarily driven by increased inventory purchases. We expect our inventory levels to decline in the back half of the year, contributing towards returning to positive cash flow for operations for 2023.
We ended the quarter with $287.6 million in cash, cash equivalents and short-term deposits compared to $327.8 million at the end of 2022. Our balance sheet and cash generation remains strong. Specifically, we are well-capitalized and well-positioned to capture value-enhancing market opportunities as they are identified. Now let me turn to our outlook for 2023 and the medium term. We expect the ongoing challenging macro backdrop to most likely persist for March of 2023, continuing to cause delayed purchases, longer sales cycles and overall inflationary and recessionary concerns reflecting in buyers' behavior.
Based on our first quarter results and current visibility of our end markets, we're updating our full year revenue guidance as follows: we are raising the low end, narrowing the range now expected to be between $630 million to $670 million, with sequential quarterly revenue growth. While we are still experiencing continued softness in the second quarter, we expect that we will see notably higher growth in the second half. From a gross margin perspective, we continue to expect full year 2023 to be in the range of 48% to 49%, with improved year-over-year growth in the second half of 2023. We expect our margins to get back over 50% next year.
In 2023, we expect our operating expenses to be in the range of approximately $290 million to $300 million. We continue to expect non-GAAP operating margins to be in the range of 2.5% to 3.5% for the full year. In the medium term, we expect non-GAAP operating margins to achieve double digits as our growth plans unfold. We anticipate a GAAP net loss of $78 million to $57 million or $1.27 to $0.83 per diluted share and a non-GAAP net income of $9 million to $17 million or $0.12 to $0.24 per diluted share for the full year of 2023.
Adjusted EBITDA is expected to be in the range of $35 million to $50 million for the year. Capital expenditures are expected to range between $20 million to $25 million for the year. We would also like to provide our expectations for some key annual financial metrics over the medium term. Starting in 2024, we expect to achieve non-GAAP gross margins above 50%, and we plan to deliver positive free cash flow. By 2026, we expect our revenue from organic growth to surplus $1 billion with adjusted EBITDA margins over 15%, driven by our innovative growth engines as we penetrate further into manufacturing and health care applications.
Please note, these are medium-term expectations. And we believe that as revenue continues to grow, the longer-term results will be even stronger. We are encouraged by the level of engagement with our customers, remain confident in our growth potential, and we will continue to monitor global issues that can have an impact. With that, let me turn the call back over to Yoav for closing remarks. Yoav?
Yoav Zeif
In closing, even as we navigate today's dynamic environment, the outlook for our customers' appreciation and adoption of 3D printing continues to grow. We have positioned the company to execute in challenging times and to lead through an expanding portfolio of hardware, materials and software solutions as the shift to additive manufacturing at scale accelerates.
We are being brought into customer opportunities as a strategic partner at higher levels than in the past because the demand to bring product to market faster to reshape supply chain and to give consumers more personalized products are very real. And we have proven our value with leaders across industries like TE Connectivity, the Mayo Clinic, NASA and Toyota. Our relentless focus on execution and continued investments for growth and ongoing profitability is expected to drive relative outperformance and enhance shareholder value.
With that, let's open it up for questions. Operator?
Question and Answer Session
Operator
(Operator Instructions) The first question today is coming from Shannon Cross of Credit Suisse.
Shannon Siemsen Cross
I'm curious as to your $1 billion target. I remember, I mean, this industry has set targets in the past and then not achieved them, and it's caused volatility to say the least. So I'm curious, can you give us more specifics and granularity behind how you came to that target number, I don't know, mix of revenue? Or just generally, what gives you confidence that you're going to be able to achieve it.
Yoav Zeif
We are quite a structured company. Nothing that we are saying on this call is based on something that we envisioned yesterday. We have long-term planning based on a 3-year strategy. And we think the quarters are very important and that's why we are delivering quarter after quarter above the expectations. But more important is the long-term foundation. And that's what we are building in strategies.
And that's why we are confident in putting outside a target of $1 billion with double-digit operating income with about 50% gross margin with about 15% EBITDA. It is based on the foundations that we have built and keep building for the last 3.5 years. And they are very clear growth drivers. It's the new technologies. We are -- yes, we are #2 or 3 in front of the new technology, which is remarkable to do it to achieve it in 2 years, but there is still so much room to grow there, new NPIs with our core technologies, the FDM, we are going to introduce amazing new technologies there.
The materials position, which cement our profitability and Covestro is a good example, the use cases that we are introducing, like the (inaudible), the fashion, the tooling, the automotive end-use parts, the software and when we're talking about software, we are talking about monetizing software because we are building and maybe we'll have time later to elaborate on it, but we are building a unique software platform, which is open and delivering added value to our huge installed base and the bioprinting. When you put all this together in a 5-year plan, and of course, we are not going now to get into the details, we get to the $1 billion with high level of profitability.
Shannon Siemsen Cross
Okay. And then can you talk a bit more the near term on consumables. It was a pretty tough compare. You did better than expected. Can you talk about how usage is changing? How much of this is the pricing of materials versus utilization PxQ, certain verticals that maybe are using more materials Just wondering what's starting that? Because I assume consumables are a pretty important part of the $1 billion as well.
Yoav Zeif
It's an essential part of the $1 billion, an essential part of the profitability. And the main driver mainly utilization and move to manufacturing. Since we are reporting every end of the year, how much of our overall sales went to end-use parts to factoring, we can see this growth year-over-year. And this growth drives the utilization because the machine that is being used for end-use parts has a completely different unit economics in terms of consumable than a machine that is being used for prototyping.
And a good example is the dental. This is end-use parts high level of consumption and add to it the Covestro portfolio that match this -- fantastic match to what we have now in terms of our hardware portfolio, we are very optimistic on the consumption going forward of material. And also this quarter, we saw increase in FDM and origin material in manufacturing. And it's also a reflection of our strength as a company given the hardware -- significant hardware sales in '21 and '22, you can see that our customers are buying our machines and they are using it. It's a long-term investment, it's reliable and it's testimonial that we are delivering value. Both in many, many different verticals, auto, aero, those are the big consumer of our materials.
Operator
The next question is coming from Troy Jensen of Lake Street Capital Markets.
Troy Donavon Jensen
First of all, congrats on the good Q1 here.
Yoav Zeif
Thank you.
Troy Donavon Jensen
So I guess could you -- could you, first of all, confirm Covestro and timing. I guess I'm curious if there is any material revenues from them in Q1 and what you think that's going to contribute for the year on a quarterly basis. That would be helpful.
Eitan Zamir
Troy, we -- thanks for the question. We closed the deal in early April. So no contribution whatsoever in Q1. However, Q2 onwards we are going to have the full impact of Covestro into our business. It's largely consumables.
Troy Donavon Jensen
Ideally, guys we would love to see organic growth of materials going forward. This is such a key focus area for you guys on the profitability, but just a thought or something to think about. But my other question would be the H350, so the nice kind of comment about the multi-shipment customer. I'm just curious, I know you got others in there also have, could you just kind of maybe contemplate, talk about status of H350 and multi-customer units?
Yoav Zeif
Yes. Thanks for the question. H350 is a fantastic machine. And it requires -- it's focused completely, I would say, 99% on manufacturing and use for professional users. And a great example is the machine bound, the large service bureau in Germany that bought one and then another four end-use parts, many of them by the way, to automotive.
However, it's a complex system that you need to be a professional and we are doing a very conscious rollout of this machine. The stuff is deliberately -- we have a slow ramp-up to make sure that our customers are happy, and we are delivering the promise both on the quality of the part and not less important, the cost per part that we believe we have the best position in the industry with it. And given the plan rollout, we expect significant better units out there in H2 because the way we are rolling it out and also because of the funnel that we are seeing now.
Troy Donavon Jensen
Okay. Good luck, keep up the good work.
Operator
The next question is coming from Greg Palm of Craig-Hallum Capital Group.
Danny James Eggerichs
This is Danny Eggerichs on for Greg today. Congrats on the good results, and I guess I'll just start with kind of what you're seeing out in the market right now from a demand perspective. Obviously, you and certainly some of your peers noted customer pushouts and maybe some increased uncertainty. So I guess what have you seen over recent weeks and with raising kind of the floor on your guidance there, what gives you confidence in hitting that range? And maybe more specifically, what kind of visibility you have in the second half?
Yoav Zeif
I don't need to share with the listeners that it's interesting macroeconomic condition for everyone in terms of growth, GDP growth, interest rates, inflation and everything. But luckily enough, 3D printing helps our customers to do better in this environment. And therefore, we see a high level of engagement especially with C-suite managers and executives, the engagement is high. We had over the last 2 quarters, some challenges with the sales cycle, which is longer, but we are starting to see that the sales cycles are somehow balancing, and we see better top-of-funnel demand.
And that's why we are confident about H2, and that's why we raised the guidance. Otherwise, we wouldn't do it. So overall, a challenging environment, but strong demand with better top-of-funnel leads and somewhat balanced sales cycle.
Danny James Eggerichs
Okay. That's good. Maybe just switching to OpEx. Operating leverage was pretty strong in the quarter. OpEx came in a bit lower than expectations. So you reiterated the full year guide for OpEx, and I guess that implies a step up throughout the remainder of the year. How should we think about OpEx in Q2 and maybe the cadence throughout the year going forward?
Eitan Zamir
Thank you, Danny, for the question. As you noted, we reiterate the OpEx guidance for the full year, while we increased the $620 million to $630 million on the revenue. That's part of our -- I believe the day-to-day management of the business, we are very tight on OpEx. We've built throughout the years, the right infrastructure to leverage the growth with minimal to no increase in OpEx.
Now the addition of Covestro starting Q2 will add a small OpEx because it comes with naturally the employees in the business. But overall, our infrastructure is built and structured in a way to keep lower -- as we grow lower OpEx as a percentage as we demonstrated this quarter, even with lower revenue.
Operator
The next question is coming from Ananda Baruah of Loop Capital.
Ananda Prosad Baruah
Yes. Two, if I could. On the denture business, congrats on getting the product out the door, how do you see the velocity of the ramping potential there, philosophically?
Yoav Zeif
Thank you for the question. Dental will be huge for us. And we are focusing on a specific segment in Dental, which we believe is the right one for us because of our capabilities and also because of the potential, which is a restorative dental use cases. So people have to buy and what we are offering here with our denture solution is a disruption to the current market. It's a complete disruption to the market. We're talking about overall dental, a $50 billion market with only the denture, a $5 billion market, which currently is labor-intensive.
And we are bringing a solution which is simple, higher quality, better aesthetic with a click practically. And it's only $5 billion in the U.S. put aside where we have the FDA approval to decide the rest of the world. We'll start to see initial revenues in H2 because we are building it step by step, building the foundation, showcasing it, making sure that dentists build the confidence around this. By the way, we are saving them between 1 to 3 visits. Think about the dentist that is sitting in its clinic and suddenly because of our solution, he needs to see the patients 1x to 3x less than on average. So we ramp it up during H2, expect significant impact in 2023. Sorry, the end of 2023 and 2024.
And we keep innovating there. It's not the last product that we are going to introduce with this unique resin and unique J5 DentaJet.
Ananda Prosad Baruah
And what -- like, I guess, when we think geographic wise, it sounds like you're starting in the U.S., what's the -- I guess is there a plan for a European rollout and other geographies? And what was the timing of those be?
Yoav Zeif
Definitely, no doubt, we have a global expansion plan and the next one is Europe. And not too far from now. And then Asia of course, the market is there, is a global plan.
Ananda Prosad Baruah
Awesome, I appreciate. One last one there. How do you guys -- like what's the sale -- what's the sort of end-to-market selling prices look like there? Do you have sort of specialty sales people? Or are you still kind of plugging into the dental equipment market?
Yoav Zeif
So we have combined plan of go-to-market with different channels, multi-channel plant for the dentures starting with building the confidence through Dental Labs with a very amazing traction from their side. Then we're also going to work with institutions or those consolidators of clinics in the U.S. and the rest of the world. We have also our own go-to-market because it's a specialized product, and we are exploring business development opportunities currently with the largest distributors in dental, and it's a combination of the 4.
Operator
Thank you. The next question is coming from Brian Drab of William Blair.
Blake Stuart Keating
This is Blake Keating on for Brian. I just wanted to ask, you guys have talked a lot about the strength that you're seeing in dental, but across other end markets, what markets are you most excited about? And what other end markets could you potentially see a pullback this type of macro environment continues longer than you expect?
Yoav Zeif
Thank you for the question. It's a great question because our problem is where to focus. We see so much enthusiasm across different verticals. And we are so strong in many of them. Just lately, I can share that we had fantastic results with government/aerospace, fantastic results. We see demand growing in automotive. We see the fashion business and of course, the dental. But for us, the strongest one are automotive and aerospace then dental. And of course, we're also very optimistic about regenerative medicine down the road, 3 to 5 years not now.
But we are building a unique position with our partners, CollPlant. So if I'm trying to summarize aerospace, automotive, Medical is the patient-specific solution and also fashion.
Blake Stuart Keating
Got it. And then on your new products, you again, talked a lot about dental, but where else are you seeing a lot of strong demand for new products and then if you can give any color on maybe the last few years of new products that have been introduced, what they're contributing now to revenue or growth. How should we think about that?
Yoav Zeif
We don't share the specific data per product. But I can share that since I joined, we replenished the portfolio. Literally, you can go to any trade show of strategies. And you can see that most of the things that we are selling are new, like our leading machine in PolyJet is J55 and the J3, which are completely new. And If I go to FDM, then we introduced the new carbon-fiber machine.
And of course, the 3 new technologies, which are well selling and we see significant demand both for the Origin and the RPS, the liquid resin solution. And now together with Covestro, are very optimistic. But put all this aside, we are focusing on use cases, use case by use case. And this is a completely new strategy that we started only 2 years ago, and it works. We see new use cases in automotive. We see new use cases in aerospace, like drones. We see new use cases with our Origin with injection molding replacements and so on and so forth.
Operator
The next question is coming from Jim Ricchiuti of Needham & Company.
James Andrew Ricchiuti
Question just on the targets that you're sharing with us today for '24 for gross margins and then your medium-term targets. I'm wondering what kind of assumptions are you making for manufacturing which I guess was what about 1/3 of the business at the end of last year. What kind of assumptions you make for '24 and looking out for the medium-term target for '26.
Eitan Zamir
So as you mentioned, the starting point as of end of 2022 is that 1/3 of the business is coming from use cases, our manufacturing. We don't share like for the future, the specific percentage, but we expect it to increase significantly, and that will drive the very positive impact of consumables on our gross margins. That's a significant portion of the increase to the 50% plus on the gross margin together with scale.
Keep in mind that Covestro that we've just acquired come with high gross margins so the combination of our journey to manufacturing of the scale of the software that comes with probably the highest gross margin out of the different trends -- the combination of all these will bring us to the 50% plus gross margin.
James Andrew Ricchiuti
That actually is a segue to the next question. I wonder if you could talk a little bit about the progress you're making in the software business and how we should be thinking about this business over the next 1 to 2 years?
Yoav Zeif
Jim, thank you for the question. We are making significant progress in software. It took us a while because we are investing have invested for the last 2 years in a new platform, but we have a very unique approach, very unique because we are not focusing on the MES part of the business. We are not going to be the one managing the whole manufacturing enterprise.
We are focusing on an AM platform, making sure that we deliver to our customers the ability to manage the entire digital thread of is additive manufacturing workflow. So that's what we are doing. And we open it up from both sides to the printers, but also to the partners or added value partners that we just announced lately, some of this, but we are building an ecosystem. What does it mean and by the way, this is something that I saw 3 years ago, and I was surprised to see that to print a part, you need to use between 3 to 6 different softwares, and you need to save export, import, it's so cumbersome.
It doesn't make sense. So we are solving it. We have one platform across our technologies and this one platform allow the customer to sit on one stream and manage its additive manufacturing operations. It's very unique to us. And the way we do it, we have a basic solution based on the GrabCAD Print. We have a basic solution. And then we have packages that we add to it. Only now we introduced the GrabCAD Print, but stay tuned, we will have more products like this with basic and additional added value. And we are going to monetize it because it's such a big opportunity. It's the smart eco said that it's above $3 billion in the next 2, 3 years. But that's not the most important thing. The most important thing that it will scale additive manufacturing and will allow to use it in manufacturing.
And we have a very unique position here because we produce the system. So we have an access to the logs. We know exactly what the customer needs and how to deliver it to him in the best way. We have the largest installed base which allow us to create this ecosystem because many other companies that are needed and are working on their solutions need the access to the installed base and we have the best operating system, the GrabCAD across all our technologies. And we heard from our customers, we want to be on one system. We want to be on one system. So I'm very optimistic about our software.
But again, it's building foundation. I started talking about, it's about building foundation. And once you build the foundation, you see that our customer are utilizing the machines. And you can see record use and consumption of our materials. This is the plan. Build the foundation and deliver value to our customers in the long term, hardware materials, software service and use cases. And it is working.
Operator
That brings us to the end of the question-and-answer session. I would like to turn the floor back over to management for any additional or closing comments.
Yoav Zeif
Thank you for joining us. Looking forward to updating you again next quarter.
Operator
Ladies and gentlemen, thank you for your participation. This concludes today's event. You may disconnect your lines or log off the webcast at this time, and enjoy the rest of your day.
